Phibro Animal Health PAHC
NASDAQ PAHC
$37.24 +1.37 (+3.82%)
At close: Oct 2, 2026 · 4:00 PM EDT

Phibro Animal Health (PAHC) Return on Sales [ROS] (2012 - 2026)

Updated

Phibro Animal Health's Return on Sales [ROS] was 12.14% in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 3.23 percentage points from 8.90% a year earlier and up 0.50 percentage points from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Return on Sales [ROS] (2012 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Return on Sales [ROS] at Phibro Animal Health came in at 12.81%, up 4.28 percentage points from FY2025.

  • Return on Sales [ROS] shows a five-year change of +3.82 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Sales [ROS] was 8.52% in FY2025 (+3.28 pp), 5.24% in FY2024 (-2.11 pp), 7.35% in FY2023 (-1.04 pp) and 8.38% in FY2022 (-0.60 pp).
  • Quarterly Return on Sales [ROS] has moved between -0.31% (fiscal Q1 2024) and 14.09% (fiscal Q1 2026) over five years.
  • Compared with a year earlier, Return on Sales [ROS] has increased for eight straight quarters, with an average year-over-year change of +3.88 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was fiscal Q1 2026 (a gain of 7.29 percentage points); the worst was fiscal Q1 2024 (a drop of 6.20 percentage points).
  • Per Business Quant data, PAHC's Return on Sales [ROS] in the three fiscal quarters before Q4 2026 was 11.64% (Q3 2026), 13.46% (Q2 2026) and 14.09% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Phibro Animal Health 1.51 Bn 1.19 Bn 134.40 Mn 12.14%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.14%
Mar 31, 2026 11.64%
Dec 31, 2025 13.46%
Sep 30, 2025 14.09%
Jun 30, 2025 8.90%
Mar 31, 2025 9.64%
Dec 31, 2024 8.26%
Sep 30, 2024 6.80%
Jun 30, 2024 6.74%
Mar 31, 2024 7.57%
Dec 31, 2023 6.28%
Sep 30, 2023 -0.31%
Jun 30, 2023 9.32%
Mar 31, 2023 7.55%
Dec 31, 2022 6.48%
Sep 30, 2022 5.89%
Jun 30, 2022 8.97%
Mar 31, 2022 8.01%
Dec 31, 2021 9.58%
Sep 30, 2021 6.81%
API Access

Phibro Animal Health Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PAHC&period=max&api_key=YOUR_API_KEY